Navigation Links
Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin

MAPLE GROVE, Minn., Sept. 1, 2011 /PRNewswire/ -- People seeking support for healthy good cholesterol from a "flush-free" niacin supplement, prepare to be disappointed – and to make a return trip to your local pharmacy. According to leading cardiologist, Dr. Carl Lavie, medical director of Cardiac Rehabilitation and Prevention, John Ochsner Heart and Vascular Institute, New Orleans, LA, "flush-free" niacin may not cause flushing, but it has not been clinically proven to support good cholesterol (HDL). It is niacin in the form of nicotinic acid, the key ingredient in Slo-Niacin®, that has been clinically proven to support good cholesterol.

"Many patients are lured in to buy niacin supplements labeled as 'flush-free' to avoid the possible side effect of flushing, but when it comes to supporting healthy good cholesterol, I cannot stress enough that 'flush-free' niacin has not been shown to have any significant effect on good cholesterol, also known as HDL, which is an important factor in overall heart health," said Dr. Lavie. "For those worried about flushing, I have recommended Slo-Niacin®, which utilizes a unique polygel® controlled-release system that gradually delivers nicotinic acid into the body, and is designed to reduce the likelihood of flushing. Studies have shown that taking one aspirin or ibuprofen before niacin consumption may also help to reduce flushing."

About Niacin and Good Cholesterol (HDL)Niacin is a type of B vitamin that occurs naturally and aids in the function of the digestive system, skin, and nervous system and can help maintain good cholesterol within the normal range. Niacin, or nicotinic acid, has been used since the 1950s to support healthy good cholesterol. Niacin in the form of nicotinic acid is clinically proven to support good cholesterol (HDL). High-density lipoprotein (HDL) cholesterol is known as good cholesterol because it is thought to help move cholesterol out of the arteries and into the liver so the body can get rid of it. A normal level of HDL cholesterol in your blood is higher than 40 mg/dL.  

About Slo-Niacin® TabletsSlo-Niacin® Tablets utilize a unique polygel® controlled-release system, not available in other dietary supplement niacin products, that gradually delivers nicotinic acid into the body and is designed to reduce the likelihood of flushing commonly associated with immediate-release niacin use. At approximately $16 for one-hundred 500 mg tablets, Slo-Niacin® Tablets are an affordable option to help support a healthy heart. To support individual heart health needs, Slo-Niacin® Tablets are available in three strengths (250 mg, 500 mg, and 750 mg).

Slo-Niacin® Tablets are manufactured by Upsher-Smith Laboratories, Inc., a trusted manufacturer of high-quality dietary supplement and prescription products since 1919. Over the last 20 years, more than 12 million bottles have been sold.  Slo-Niacin® Tablets are conveniently available at pharmacies and other retailers nationwide, without a prescription. For more information, coupons, and a store locator, visit

About Upsher-Smith Laboratories, Inc.Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of our customers. Upsher-Smith prides itself in providing safe, effective, and economical therapies to the ever-changing healthcare environment. For additional information about Upsher-Smith, visit statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.Dr. Lavie consults on behalf of Upsher-Smith Laboratories, Inc.Sources:Data on File. Upsher-Smith Laboratories, Inc.; 2011.Slo-Niacin product information. Upsher-Smith Laboratories, 2011. Accessed July 22, 2011.  Mayo Clinic Web site. Accessed Aug. 9, 2011.NHLBI: National Cholesterol Education Program. Accessed Aug. 9, 2011Harvard Health Lett. 2007;July:7. Accessed April 11, 2011.

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 26, 2015  The total global healthcare industry is expected ... Latin America has the highest projected ... Japan ), is second with growth projected ... face increased healthcare expenditure. In 2013-2014, total government funded healthcare ... in 2008-2009 to 41.2% in 2013-2014. In real terms, out ...
Breaking Medicine Technology:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for ... of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
Breaking Medicine News(10 mins):